Kaposi's Sarcoma clinical trials at UCSF
2 research studies open to eligible people
Kaposi's sarcoma is a cancer that develops from the cells that line blood vessels. UCSF is collecting samples of blood and tissue to study cancers linked to HIV/AIDS. UCSF is also researching the effectiveness of a drug called ixazomib in treating Kaposi's sarcoma tumors.
Ixazomib for Kaposi Sarcoma
open to eligible people ages 18 years and up
This phase II trial studies how well ixazomib works in treating patients with Kaposi sarcoma. Ixazomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
San Francisco, California and other locations
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
open to eligible people ages 18 years and up
This study collects blood and tissue samples for research of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)-related cancers. Collecting blood and tissue samples and studying biomarkers in the laboratory may help doctors to learn how are biologic or genetic factors related to HIV and cancers that occur commonly in people living with HIV.
San Francisco, California and other locations
Last updated: